These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9712564)

  • 41. Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer.
    Krempien R; Roeder F; Oertel S; Roebel M; Weitz J; Hensley FW; Timke C; Funk A; Bischof M; Zabel-Du Bois A; Niethammer AG; Eble MJ; Buchler MW; Treiber M; Debus J
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1143-51. PubMed ID: 16979835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Neoadjuvant radiochemotherapy treatment in locally advanced rectal adenocarcinoma].
    Carau B; Orrù P; Orrù S; Dessì M; Nagliati M; Lay G; Maxia V; Casula G; Amichetti M
    Tumori; 2003; 89(4 Suppl):7-8. PubMed ID: 12903531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase II study of preoperative irradiation and chemotherapy with capecitabine in patients with locally advanced rectal carcinoma.
    Lay GC; Caraul B; Dessì M; Orrù S; Murtas R; Deidda MA; Farigu R; Farci D; Maxia L; Casula G; Amichetti M
    J Exp Clin Cancer Res; 2007 Mar; 26(1):61-70. PubMed ID: 17550133
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined-modality therapy in locally advanced primary rectal cancer.
    Ratto C; Valentini V; Morganti AG; Barbaro B; Coco C; Sofo L; Balducci M; Gentile PC; Pacelli F; Doglietto GB; Picciocchi A; Cellini N
    Dis Colon Rectum; 2003 Jan; 46(1):59-67. PubMed ID: 12544523
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.
    Smalley SR; Benedetti JK; Williamson SK; Robertson JM; Estes NC; Maher T; Fisher B; Rich TA; Martenson JA; Kugler JW; Benson AB; Haller DG; Mayer RJ; Atkins JN; Cripps C; Pedersen J; Periman PO; Tanaka MS; Leichman CG; Macdonald JS
    J Clin Oncol; 2006 Aug; 24(22):3542-7. PubMed ID: 16877719
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early clinical results from chemoradiation with 5-fluorouracil and oxaliplatin for locally advanced rectal cancer.
    Lawson JD; Kauh J; Koshy M; Staley C; Landry J
    Clin Colorectal Cancer; 2008 Sep; 7(5):325-30. PubMed ID: 18794065
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
    Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcome of rectal and sigmoid carcinoma patients receiving adjuvant chemoradiotherapy in Marmara University Hospital.
    Yumuk PF; Abacioglu U; Caglar H; Gumus M; Sengoz M; Turhal NS
    J Chemother; 2003 Dec; 15(6):603-6. PubMed ID: 14998088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Feasibility and first results of multimodality treatment, combining EBRT, extensive surgery, and IOERT in locally advanced primary rectal cancer.
    Mannaerts GH; Martijn H; Crommelin MA; Dries W; Repelaer van Driel OJ; Rutten HJ
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):425-33. PubMed ID: 10802370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumour regression grading in the evaluation of tumour response after different preoperative radiotherapy treatments for rectal carcinoma.
    Vironen J; Juhola M; Kairaluoma M; Jantunen I; Kellokumpu I
    Int J Colorectal Dis; 2005 Sep; 20(5):440-5. PubMed ID: 15856263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Five fractions of preoperative radiotherapy for selected cases of rectal carcinoma: long-term tumor control and tolerance to treatment.
    Myerson RJ; Genovesi D; Lockett MA; Birnbaum E; Fleshman J; Fry R; Kodner I; Menteer J; Picus J; Read T; Walz B
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):537-43. PubMed ID: 10078634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A pilot study of preoperative continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancer.
    Anscher MS; Lee C; Hurwitz H; Tyler D; Prosnitz LR; Jowell P; Rosner G; Samulski T; Dewhirst MW
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):719-24. PubMed ID: 10837956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical outcome of interstitial pulsed dose rate brachytherapy in multimodality treatment of locally advanced primary or recurrent rectal and sigmoid cancer with high risk of incomplete microscopic resection.
    Nielsen MB; Rasmussen PC; Tanderup K; Nielsen SK; Fokdal L; Laurberg S; Lindegaard JC
    Acta Oncol; 2016 Dec; 55(12):1408-1413. PubMed ID: 27537776
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Postoperative adjuvant radio(chemo)therapy for rectal cancer: an appraisal.
    Scandolaro L; Cazzaniga LF; Bianchi E; Cagna E; Prina M; Valli MC; Barsacchi L; Frigerio M
    Tumori; 2004; 90(2):208-15. PubMed ID: 15237584
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
    ; Ryan DP; Niedzwiecki D; Hollis D; Mediema BE; Wadler S; Tepper JE; Goldberg RM; Mayer RJ
    J Clin Oncol; 2006 Jun; 24(16):2557-62. PubMed ID: 16636336
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis.
    Das P; Lin EH; Bhatia S; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Hoff PM; Eng C; Wolff RA; Delclos ME; Krishnan S; Janjan NA; Crane CH
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1378-83. PubMed ID: 17056196
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon.
    Czito BG; Hong TJ; Cohen DP; Tyler DS; Lee CG; Anscher MS; Ludwig KA; Seigler HF; Mantyh C; Morse MA; Lockhart AC; Petros WP; Honeycutt W; Spector NL; Ertel PJ; Mangum SG; Hurwitz HI
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):779-85. PubMed ID: 14967434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A retrospective comparison of concurrent bolus 5-fluorouracil or raltitrexed in preoperative chemoradiation for locally advanced rectal cancer.
    Yoney A; Askaroglu B; Hancilar T; Isikli L; Unsal M
    Hematol Oncol Stem Cell Ther; 2008; 1(1):28-33. PubMed ID: 20063525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Kurt M; Ozkan L; Ercan I; Kahraman S; Zorluoglu A; Gurel S; Memik F; Engin K
    Hepatogastroenterology; 2005; 52(64):1095-100. PubMed ID: 16001638
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preoperative irinotecan/5-FU/leucovorin plus concurrent radiotherapy in rectal cancer.
    Chitapanarux I; Kamnerdsupaphon P; Lorvidhaya V; Siriwittayakorn P; Tharavichitkul E; Somwangprasert A; Sukthomya V
    Gan To Kagaku Ryoho; 2008 Jan; 35(1):77-82. PubMed ID: 18195532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.